Formula: | C20H27ClN8OS |
Molecular Weight: | 463.01 |
Rotatable Bond Donors: | 8 |
clogP: | 3.64 |
Topological Polar Surface Area: | 107.26 |
Lipinski's RO5: | MW: 463.01 HBA: 9 HBD: 3 RB: 8 LogP: 3.64 |
Rule of Three: | MW: 463.01 HBA: 9 HBD: 3 RB: 8 LogP: 3.64 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC58660958 | 1.0 | ZINC58660958 RDKit 3D 30 33 0 0 0 0 0 0 0 0999 V2000 3.5780 0.1433 2.3029 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8441 0.5818 1.6062 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7613 0.2265 0.1943 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3415 1.4424 -0.5111 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1259 1.1851 -1.3294 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8285 0.9051 -0.8155 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9029 0.7206 -1.8185 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4201 0.4281 -1.7610 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.2172 0.2549 -0.6374 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7580 0.3972 0.5922 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.6039 0.2077 1.6712 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9990 0.3819 3.0205 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9038 -0.1181 1.5645 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4189 -0.2714 0.2925 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.6701 -0.5906 -0.1649 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9422 -0.8901 0.6467 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.2265 -1.2176 0.1701 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.0992 -1.4144 1.1619 N 0 0 0 0 0 0 0 0 0 0 0 0 -7.3634 -1.2113 2.2669 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.0592 -0.8927 2.0142 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5591 -0.5899 -1.5406 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2795 -0.2803 -1.9366 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.6226 -0.0962 -0.8100 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7277 0.9295 -3.3095 S 0 0 0 0 0 0 0 0 0 0 0 0 3.2188 1.2577 -2.6590 N 0 0 0 0 0 0 0 0 0 0 0 0 6.0692 -0.2410 -0.3012 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1431 0.8326 -0.2167 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9193 -0.6320 -1.7614 C 0 0 0 0 0 0 0 0 0 0 0 0 6.5220 -1.5171 0.4145 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1601 -1.2467 1.6543 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 11 13 2 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 1 0 15 21 2 0 21 22 1 0 22 23 2 0 7 24 1 0 24 25 1 0 3 26 1 0 26 27 1 0 26 28 1 0 26 29 1 0 29 30 1 0 25 5 2 0 23 9 1 0 23 14 1 0 20 16 2 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |